Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Peter, Ruf"'
Autor:
Sara Marie Ivasko, Kathleen Anders, Laura Grunewald, Michael Launspach, Anika Klaus, Silke Schwiebert, Peter Ruf, Horst Lindhofer, Holger N. Lode, Lena Andersch, Johannes H. Schulte, Angelika Eggert, Patrick Hundsdoerfer, Annette Künkele, Felix Zirngibl
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
IntroductionDespite advances in treating high-risk neuroblastoma, 50-60% of patients still suffer relapse, necessitating new treatment options. Bispecific trifunctional antibodies (trAbs) are a promising new class of immunotherapy. TrAbs are heterodi
Externí odkaz:
https://doaj.org/article/4e199ae7fd1b49e29afc664c4e0bbbe6
Autor:
Andreas Winter, Kai Zacharowski, Patrick Meybohm, Andreas Schnitzbauer, Peter Ruf, Claudia Kellermann, Horst Lindhofer
Publikováno v:
BMC Anesthesiology, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Intraoperative blood salvage (IBS) is regarded as an alternative to allogeneic blood transfusion excluding the risks associated with allogeneic blood. Currently, IBS is generally avoided in tumor surgeries due to concern for poten
Externí odkaz:
https://doaj.org/article/ba1d02f44a6647b1b000b90124923843
Autor:
Annette Künkele, Angelika Eggert, Johannes H Schulte, Anika Klaus, Horst Lindhofer, Felix Zirngibl, Sara M Ivasko, Laura Grunewald, Silke Schwiebert, Peter Ruf, Kathy Astrahantseff, Lena Andersch, Holger N Lode, Kathleen Anders, Patrick Hundsdoerfer
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Background Neuroblastoma is the most common extracranial solid tumor of childhood. Patients with high-risk disease undergo extremely aggressive therapy and nonetheless have cure rates below 50%. Treatment with the ch14.18 monoclonal antibody (dinutux
Externí odkaz:
https://doaj.org/article/3775a0fe4d3545de91f6ca37d90c877c
Autor:
Ralph Mocikat, Horst Lindhofer, Raymund Buhmann, Frauke Neff, Nina Eissler, Peter Ruf, Nina Deppisch
Trifunctional bispecific antibodies (trAb) are novel anticancer drugs that recruit and activate different types of immune effector cells at the targeted tumor. Thus, tumor cells are effectively eliminated and a long-lasting tumor-specific T-cell memo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::251f0d06a62bf4124467a82046de7771
https://doi.org/10.1158/1535-7163.c.6538330.v1
https://doi.org/10.1158/1535-7163.c.6538330.v1
Autor:
Urs Peter Ruf
Publikováno v:
Difference and Sameness as Modes of Integration ISBN: 9781785337161
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76d71ae3d8edf8fdbb174867c391c343
https://doi.org/10.1515/9781785337161-004
https://doi.org/10.1515/9781785337161-004
Publikováno v:
Cancer Immunology, Immunotherapy
Transurethral resection of the tumor (TUR-B) followed by adjuvant intravesical treatment with cytostatic drugs or Bacillus Calmette–Guérin (BCG) as standard therapy of non-muscle-invasive bladder cancer (NMIBC) is associated with a high recurrence
Publikováno v:
Molecular Medicine, Vol 19, Iss 1, Pp 54-61 (2013)
Abstract Trifunctional bispecific antibodies (trAbs) used in tumor immunotherapy have the unique ability to recruit T cells toward antigens on the tumor cell surface and, moreover, to activate accessory cells through their immunoglobulin Fc region in
Externí odkaz:
https://doaj.org/article/08ec4f4b1668430db55894883c0eab70
Autor:
Urs Peter Ruf
»Ending Slavery« offers insights into the »how« of practices of slavery that persist in parts of Mauritania up to the present day. It brings to the light the gendered structures of Moorish slavery, and examines their impact on strategies and tact
Autor:
Andreas, Winter, Kai, Zacharowski, Patrick, Meybohm, Andreas, Schnitzbauer, Peter, Ruf, Claudia, Kellermann, Horst, Lindhofer
Publikováno v:
BMC Anesthesiology, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Anesthesiology
BMC Anesthesiology
Background:Intraoperative blood salvage (IBS) is regarded as an alternative to allogeneic blood transfusion excluding the risks associated with allogeneic blood. Currently, IBS is generally avoided in tumor surgeries due to concern for potential meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ee26ba1bd584ec538baaa8607a2ea50
https://doi.org/10.21203/rs.3.rs-275266/v1
https://doi.org/10.21203/rs.3.rs-275266/v1
Autor:
Felix Albert, Aleksander Antoniewicz, Tobias Grantzow, Guenter Fingerle-Rowson, Peter Ruf, Horst Lindhofer, Maximilian Kriegmair, Ralph Oberneder
Publikováno v:
Journal of Clinical Oncology. 40:e16555-e16555
e16555 Background: Tx of high-risk NMIBC is challenging due to a high risk of recurrence. Novel therapeutic options are highly anticipated to avoid cystectomy and disease progression. Malignant transitional cells express EpCAM. The trifunctional anti